Protenix-v1, a fully open co-folding model reporting AlphaFold3-level performance under matched conditions, is now available in ApherisFold. Teams can run and benchmark it locally on proprietary datasets, compare it to OpenFold3 and Boltz-2, and evaluate performance within real DMTA workflows.
Founding members include Lundbeck, Orion Pharma, Recursion, and Servier, among other pharma and biotech companies
Apheris, a leading provider of AI applications for drug discovery, today announced the launch of ApherisFold, an enterprise software product that enables pharmaceutical organizations to securely run, benchmark, and fine-tune the latest co-folding models, including OpenFold3 and Boltz-2, directly within their own IT environments.
